DEPARLE NANCY ANN 4

What Happened

• Nancy Ann DeParle, a director of HCA Healthcare (HCA), was granted 509 restricted share units (RSUs) on 2026-04-28. The acquisition is reported at $0.00 (code A — grant/award), so no cash was paid. The filing was submitted on 2026-04-30.

Key Details

• Transaction date: 2026-04-28; Form 4 filed: 2026-04-30 (timely).
• Transaction type/code: Grant/Award (A).
• Amount: 509 RSUs; reported acquisition price: $0.00; reported cash value: $0.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote (F1): These 509 RSUs represent common stock underlying an annual director equity award and vest on the earlier of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date.
• No 10b5-1 plan, tax-withholding, or sale was reported in this transaction.

Context

• RSUs are a form of equity compensation that convert into actual shares only upon vesting; they are not an open-market purchase or sale. Grants like this are routine director compensation and do not by themselves indicate a buy or sell signal. The reported $0.00 reflects that this is an award rather than a paid purchase.